North America CPAP Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

North America CPAP Devices Market Size

• The North America CPAP devices market size was valued at USD 1.48 billion in 2024 and is expected to reach USD 2.49 billion by 2032, at a CAGR of 6.70% during the forecast period
• The market growth is primarily driven by the rising prevalence of sleep apnea, coupled with increasing awareness and diagnosis rates across the region. A growing aging population and lifestyle-related health conditions are further intensifying the demand for effective respiratory care solutions
• In addition, advancements in CPAP device design, portability, and connectivity are enhancing patient compliance and fueling market expansion. These trends, along with favorable reimbursement policies and healthcare infrastructure, are collectively propelling the market forward, reinforcing CPAP devices as a cornerstone in sleep therapy management in North America

North America CPAP Devices Market Analysis

• CPAP devices, offering continuous positive airway pressure for individuals with obstructive sleep apnea (OSA), are becoming essential tools in respiratory care across both home and clinical environments due to their non-invasive nature, therapeutic effectiveness, and integration with remote monitoring technologies
• The rising demand for CPAP devices is primarily fueled by increasing diagnosis rates of sleep disorders, a growing elderly population, and greater awareness of the health risks associated with untreated OSA
• U.S. dominated the North America CPAP devices market with the largest revenue share of 78.8% in 2024, supported by advanced healthcare systems, favorable reimbursement policies, and a strong presence of leading manufacturers, with significant adoption driven by the shift toward home-based sleep therapy and digital health platforms
• Canada is expected to be the fastest growing country in the North America CPAP devices market during the forecast period due to rising sleep disorder awareness, expanding sleep medicine infrastructure, and favorable public health initiatives supporting CPAP adoption
• The CPAP Devices product segment dominated the North America market with a 62.9% share in 2024, driven by increasing demand for reliable and effective treatment solutions for sleep apnea across both clinical and home settings

Report Scope and North America CPAP Devices Market Segmentation        

North America CPAP Devices Market Trends

“Advancements in Connectivity and Remote Monitoring”

• A prominent trend shaping the North America CPAP devices market is the integration of wireless connectivity and remote monitoring technologies, enabling more personalized, convenient, and effective management of sleep apnea treatment
  • For instance, ResMed’s AirSense 11 and Philips’ DreamStation devices offer cloud-based data sharing, allowing healthcare providers to monitor patient compliance and therapy effectiveness in real time. These systems can send alerts, track sleep patterns, and adjust therapy settings remotely
• Bluetooth and Wi-Fi-enabled CPAP devices are also enhancing patient engagement by syncing with mobile apps, enabling users to track their progress, receive feedback, and access educational content, thus boosting long-term compliance
• This integration of digital health tools into CPAP therapy is transforming care delivery by supporting telemedicine and reducing the need for frequent in-person visits, especially in remote and underserved regions
• The trend toward connected CPAP systems is creating a more interactive and supportive user experience, empowering patients to actively participate in their treatment journey. Consequently, companies such as 3B Medical and Fisher & Paykel are expanding their product lines to include devices with integrated digital features
• As healthcare systems in the U.S. and Canada shift toward outcome-based models, the demand for smart CPAP devices that provide real-time data insights is accelerating, particularly among home care providers and sleep clinics seeking to improve therapy adherence and treatment outcomes

North America CPAP Devices Market Dynamics

Driver

“Growing Prevalence of Sleep Apnea and Home-based Care Adoption”

• The increasing prevalence of obstructive sleep apnea (OSA) across the U.S. and Canada is a major factor fueling the demand for CPAP devices. Aging populations, rising obesity rates, and greater public awareness are contributing to higher diagnosis and treatment rates
  • For instance, according to the American Academy of Sleep Medicine, approximately 30 million adults in the U.S. suffer from sleep apnea, with only a fraction currently diagnosed, presenting significant growth opportunities for CPAP manufacturers
• The COVID-19 pandemic accelerated the shift toward home-based healthcare, making at-home sleep studies and CPAP therapy more common. This shift continues to influence buying behaviors, with patients seeking portable, easy-to-use devices supported by telehealth services
• The convenience of home care, reduced hospital visits, and growing insurer support for at-home treatments are making CPAP devices a cornerstone in respiratory care management.
• Leading companies such as ResMed, Philips, and DeVilbiss are capitalizing on this trend by expanding their direct-to-consumer channels and investing in patient education and remote setup solutions

Restraint/Challenge

“Compliance Issues and High Device Costs”

• One of the key challenges facing the North America CPAP market is patient non-compliance, often due to discomfort, noise, or difficulty adjusting to the therapy. Many users discontinue use within the first few weeks, limiting the clinical effectiveness of CPAP treatment
  • For instance, a study published by the American Journal of Respiratory and Critical Care Medicine found that nearly 50% of CPAP users stop using their devices within the first year due to discomfort or inconvenience, highlighting a major adherence issue despite the proven benefits of treatment
• To address this, manufacturers are developing quieter, more comfortable masks and auto-adjusting CPAP devices, but user discomfort and poor adherence still remain barriers to sustained use
• In addition, the relatively high cost of CPAP machines and accessories, especially without comprehensive insurance coverage, can be prohibitive for some patients. While basic models are becoming more affordable, advanced units with smart features remain costly
• Insurance reimbursement limitations and out-of-pocket expenses may deter price-sensitive consumers, particularly those with high-deductible health plans or limited coverage
• Overcoming these barriers requires continued innovation in device design for comfort, broader insurance collaboration, and patient education to improve adherence and drive long-term market growth

North America CPAP Devices Market Scope

The market is segmented on the basis of product type, modality, and end user.

• By Product Type

On the basis of product type, the North America CPAP devices market is segmented into CPAP devices and consumables. The CPAP devices segment dominated the market with the largest revenue share of 62.9% in 2024, driven by the increasing diagnosis of obstructive sleep apnea and the growing shift toward non-invasive respiratory therapies. CPAP devices are a foundational treatment for OSA and are commonly prescribed for both home and clinical use. The demand for CPAP machines continues to rise with technological advancements, including auto-adjusting pressure and integration with digital monitoring tools.

The consumables segment, including masks, tubing, filters, and humidifiers, is expected to grow steadily during forecast period, due to the recurring need for replacement and maintenance. As patient adherence increases and home therapy becomes more widespread, the consumables segment plays a critical role in supporting consistent CPAP therapy and hygiene.

• By Modality

On the basis of modality, the North America CPAP devices market is segmented into standalone and portable devices. The standalone segment held the largest market revenue share of 54.1% in 2024, due to its reliability, robust features, and widespread use in both home and sleep clinic settings. Standalone CPAP units are typically equipped with comprehensive functionalities such as humidifiers, data recording, and user-friendly interfaces, making them a preferred choice for patients newly diagnosed with OSA.

The portable segment is anticipated to witness the fastest growth from 2025 to 2032, driven by the rising demand for travel-friendly respiratory devices. Portable CPAP machines appeal particularly to frequent travelers and active individuals, offering lightweight, compact designs without compromising treatment effectiveness. Advances in battery life and noise reduction further contribute to their growing popularity.

• By End User

On the basis of end user, the North America CPAP devices market is segmented into home care, hospitals, private clinics, and others. The home care segment dominated the market with the largest revenue share of 48.7% in 2024, reflecting a strong shift toward self-managed sleep therapy supported by telehealth and remote monitoring solutions. Patients prefer home-based CPAP therapy for its convenience, cost-effectiveness, and privacy. Insurers and healthcare providers are also increasingly promoting home care to reduce hospital admissions and improve treatment compliance.

The hospital segment is expected to witness fastest growth during forecast period, as it remain important for initial diagnosis and therapy titration, but the ongoing management of CPAP therapy is increasingly transitioning to the home setting, especially with the growing availability of user-friendly devices and digital support tools.

North America CPAP Devices Market Regional Analysis

• The U.S. dominated the North America CPAP devices market with the largest revenue share of 78.8% in 2024, supported by advanced healthcare systems, favorable reimbursement policies, and a strong presence of leading manufacturers, with significant adoption driven by the shift toward home-based sleep therapy and digital health platforms
• Consumers in the U.S. highly value technologically advanced, user-friendly devices that offer remote monitoring, digital tracking, and personalized therapy options, supporting better adherence and health outcomes
• This strong market leadership is further supported by widespread insurance coverage, rising public awareness of sleep health, and the presence of major global CPAP manufacturers, positioning the U.S. as the key driver of regional market growth

U.S. North America CPAP Devices Market Insight

The U.S. CPAP devices market captured the largest revenue share of 78.8% in 2024 within North America, driven by the widespread prevalence of obstructive sleep apnea and a strong healthcare infrastructure supporting diagnosis and treatment. The growing demand for home-based respiratory care, alongside advancements in device connectivity and remote monitoring, is significantly accelerating CPAP adoption. In addition, the availability of insurance coverage, a high rate of sleep disorder awareness, and strong market presence of key players such as ResMed and Philips are contributing to the continued expansion of the CPAP devices market in the U.S.

Canada CPAP Devices Market Insight

The Canada CPAP devices market is projected to grow at a notable CAGR throughout the forecast period, fueled by rising diagnosis rates of sleep apnea and government support for chronic disease management. The Canadian healthcare system’s focus on preventive care and at-home treatment options supports the adoption of CPAP therapy. Increased investment in telehealth, coupled with awareness initiatives by health organizations, is further promoting the use of CPAP devices across the country, particularly in remote and underserved areas.

Mexico CPAP Devices Market Insight

The Mexico CPAP devices market is expected to grow steadily over the forecast period, driven by an increasing incidence of respiratory disorders and a growing awareness of sleep-related health issues. Improvements in healthcare access and infrastructure, particularly in urban centers, are encouraging more diagnoses and treatment of sleep apnea. As the private healthcare sector expands and more affordable CPAP options become available, the market is anticipated to witness a broader consumer reach, especially among middle-income households seeking cost-effective treatment solutions.

North America CPAP Devices Market Share

The North America CPAP Devices industry is primarily led by well-established companies, including:

• ResMed Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Fisher & Paykel Healthcare Limited (New Zealand)
• BMC Medical Co., Ltd. (China)
• Apex Medical Corp. (Taiwan)
• 3B Medical, Inc. (U.S.)
• React Health (U.S.)
• BMC Medical Co., Ltd. (China)
• Apex Medical Corp. (Taiwan)
• Somnetics International, Inc. (U.S.)
• Compass Health Brands (U.S.)
• Invacare Corporation (U.S.)
• Sunset Healthcare Solutions Inc. (U.S.)
• Sanrai International (U.S.)
• Vyaire Medical, Inc. (U.S.)
• Human Design Medical (U.S.)
• Curative Medical Inc. (U.S.)
• Breas Medical AB (Sweden)
• Nidek Medical Products, Inc. (U.S.)

What are the Recent Developments in North America CPAP Devices Market?

• In March 2024, ResMed Inc., a leading CPAP device manufacturer based in the U.S., launched the AirSense 11 AutoSet across North America, featuring enhanced digital health integration and real-time data sharing for healthcare providers. This next-generation device aims to improve patient adherence through personalized coaching via the myAir app, reinforcing ResMed’s focus on user engagement and remote therapy management
• In February 2024, Philips Respironics resumed distribution of select CPAP devices in the U.S. following FDA approval after the recall of certain models in 2021. The company introduced improved DreamStation 2 models with advanced filtration and noise-reduction technology, signaling its renewed commitment to safety, innovation, and restoring market confidence
• In January 2024, 3B Medical Inc. introduced the Luna G3 Auto-CPAP with integrated cellular connectivity in North America, aiming to streamline remote monitoring for clinicians and enhance patient support. This development caters to the growing demand for home-based care solutions and reinforces 3B Medical’s position in the competitive North American sleep therapy market
• In October 2023, Fisher & Paykel Healthcare expanded its U.S. operations with a new logistics and distribution center in Texas to improve supply chain efficiency and meet the rising demand for CPAP devices and consumables across the region. This strategic move supports the company's North American market penetration and responsiveness to customer needs
• In August 2023, React Health (formerly Drive DeVilbiss Healthcare) partnered with a network of North American sleep clinics to launch a CPAP adherence improvement program, combining telehealth consultations with data-driven insights from their IntelliPAP AutoAdjust system. This initiative demonstrates the industry's increasing shift toward integrated, outcomes-based therapy solutions aimed at boosting long-term compliance and patient outcomes

SKU-72896